| Authors: |
Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: mdimop@med.uoa.gr., Hungria VTM; Department of Hematology, Clinica São Germano, São Paulo, Brazil., Radinoff A; Department of Clinical Haematology, University Hospital St Ivan Rilski EAD, Sofia, Bulgaria., Delimpasi S; General Hospital Evangelismos, Athens, Greece., Mikala G; Department of Hematology and Stem Cell Transplantation, South Pest Central Hospital, National Institute for Haematology and Infectious Diseases, Budapest, Hungary., Masszi T; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Li J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Capra M; Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil., Maiolino A; Instituto Americas de Ensino, Pesquisa e Inovacao, Rio de Janeiro, Brazil., Pappa V; Second Department of Internal Medicine and Research Unit, Haematology Unit, University General Hospital Attikon, Athens, Greece., Chraniuk D; Department of Haematology, Wojewodzki Szpital Zespolony, Torun, Poland., Osipov I; VA Almazov National Medical Research Centre, Saint Petersburg, Russia., Leleu X; Haematology, PRC, CHU Poitiers, Poitiers, France., Low M; Monash Haematology, Monash Health, Monash University, Clayton Campus, Clayton VIC, Australia., Matsumoto M; Department of Hematology, Shibukawa Medical Center, Shibukawa, Japan., Sule N; Oncology Clinical Development, GSK, Upper Providence, PA, USA., Li M; Oncology Clinical Development, GSK, Upper Providence, PA, USA., McKeown A; Oncology Clinical Development, GSK, Stevenage, UK., He W; Oncology Biostatistics, GSK, Waltham, MA, USA., Bright S; Pharmacovigilance, GSK, Upper Providence, PA, USA., Currie B; Patients Centered Outcomes, GSK, Rockville, MD, USA., Perera S; Value Evidence and Outcomes, GSK, London, UK., Boyle J; Global Clinical Operations, GSK, London, UK., Roy-Ghanta S; Oncology Clinical Development, GSK, Upper Providence, PA, USA., Opalinska J; Oncology Clinical Development, GSK, Upper Providence, PA, USA., Weisel K; University Medical Center of Hamburg-Eppendorf, Hamburg, Germany. |
